Changiz Taghibiglou, Pharm. D., Ph.D. - Publications

Affiliations: 
University of Saskatchewan, Saskatoon, SK, Canada 

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Sekar S, Zhang Y, Miranzadeh Mahabadi H, Parvizi A, Taghibiglou C. Low Field Magnetic Stimulation Restores Cognitive and Motor Functions in the Mouse Model of Repeated Traumatic Brain Injury: Role of Cellular Prion Protein. Journal of Neurotrauma. PMID 31020907 DOI: 10.1089/neu.2018.5918  0.44
2018 Mohammad H, Sekar S, Wei Z, Moien-Afshari F, Taghibiglou C. Perampanel but Not Amantadine Prevents Behavioral Alterations and Epileptogenesis in Pilocarpine Rat Model of Status Epilepticus. Molecular Neurobiology. PMID 30039334 DOI: 10.1007/s12035-018-1230-6  0.44
2017 Sekar S, Taghibiglou C. Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson's disease. Neuroscience Letters. 666: 139-143. PMID 29288045 DOI: 10.1016/j.neulet.2017.12.049  0.44
2017 Sekar S, Omran E, Gopalakrishnan V, Howland JG, Snutch TP, Taghibiglou C. Elevated sterol regulatory elementary binding protein 1 and GluA2 levels in the hippocampal nuclear fraction of Genetic Absence Epilepsy Rats from Strasbourg. Epilepsy Research. 136: 1-4. PMID 28719803 DOI: 10.1016/j.eplepsyres.2017.07.004  0.44
2017 Tang M, Taghibiglou C. The Mechanisms of Action of Curcumin in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 28527218 DOI: 10.3233/JAD-170188  0.32
2017 Siqingaowa, Sekar S, Gopalakrishnan V, Taghibiglou C. Sterol regulatory element-binding protein 1 inhibitors decrease pancreatic cancer cell viability and proliferation. Biochemical and Biophysical Research Communications. PMID 28483521 DOI: 10.1016/j.bbrc.2017.05.023  0.44
2015 Pham N, Akonasu H, Shishkin R, Taghibiglou C. Plasma soluble prion protein, a potential biomarker for sport-related concussions: a pilot study. Plos One. 10: e0117286. PMID 25643046 DOI: 10.1371/journal.pone.0117286  0.68
2015 Pham N, Sawyer TW, Wang Y, Jazii FR, Vair C, Taghibiglou C. Primary blast-induced traumatic brain injury in rats leads to increased prion protein in plasma: a potential biomarker for blast-induced traumatic brain injury. Journal of Neurotrauma. 32: 58-65. PMID 25058115 DOI: 10.1089/neu.2014.3471  0.68
2014 Pham N, Dhar A, Khalaj S, Desai K, Taghibiglou C. Down regulation of brain cellular prion protein in an animal model of insulin resistance: possible implication in increased prevalence of stroke in pre-diabetics/diabetics. Biochemical and Biophysical Research Communications. 448: 151-6. PMID 24780399 DOI: 10.1016/j.bbrc.2014.04.071  0.68
2014 Stockwell J, Abdi N, Lu X, Maheshwari O, Taghibiglou C. Novel central nervous system drug delivery systems. Chemical Biology & Drug Design. 83: 507-20. PMID 24325540 DOI: 10.1111/cbdd.12268  0.68
2013 Cho T, Ryu JK, Taghibiglou C, Ge Y, Chan AW, Liu L, Lu J, McLarnon JG, Wang YT. Long-term potentiation promotes proliferation/survival and neuronal differentiation of neural stem/progenitor cells. Plos One. 8: e76860. PMID 24146937 DOI: 10.1371/journal.pone.0076860  0.68
2013 Zhang S, Taghibiglou C, Girling K, Dong Z, Lin SZ, Lee W, Shyu WC, Wang YT. Critical role of increased PTEN nuclear translocation in excitotoxic and ischemic neuronal injuries. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 7997-8008. PMID 23637190 DOI: 10.1523/JNEUROSCI.5661-12.2013  0.68
2013 Ahmad Nasrollahi S, Taghibiglou C, Fouladdel S, Dinarvand R, Moosavi Movahedi AA, Azizi E, Farboud ES. Physicochemical and biological characterization of pep-1/elastin complexes. Chemical Biology & Drug Design. 82: 189-95. PMID 23601371 DOI: 10.1111/cbdd.12150  0.68
2013 Khalaj S, Taghibiglou C. Role of lipid transcription factor, sterol regulatory element binding protein 1 (SREBP1) in ALS: Potential therapeutic interventions Amyotrophic Lateral Sclerosis: Symptoms, Treatment and Prognosis. 57-84.  0.68
2012 Nasrollahi SA, Taghibiglou C, Azizi E, Farboud ES. Cell-penetrating peptides as a novel transdermal drug delivery system. Chemical Biology & Drug Design. 80: 639-46. PMID 22846609 DOI: 10.1111/cbdd.12008  0.68
2012 Nasrollahi SA, Fouladdel S, Taghibiglou C, Azizi E, Farboud ES. A peptide carrier for the delivery of elastin into fibroblast cells. International Journal of Dermatology. 51: 923-9. PMID 22788807 DOI: 10.1111/j.1365-4632.2011.05214.x  0.68
2012 Bradley CA, Peineau S, Taghibiglou C, Nicolas CS, Whitcomb DJ, Bortolotto ZA, Kaang BK, Cho K, Wang YT, Collingridge GL. A pivotal role of GSK-3 in synaptic plasticity. Frontiers in Molecular Neuroscience. 5: 13. PMID 22363262 DOI: 10.3389/fnmol.2012.00013  0.68
2012 Bradley CA, Peineau S, Taghibiglou C, Nicolas CS, Whitcomb DJ, Bortolotto ZA, Kaang BK, Cho K, Wang YT, Collingridge GL. A pivotal role of GSK-3 in synaptic plasticity Frontiers in Molecular Neuroscience 0.68
2011 Taghibiglou C, Lu J, Mackenzie IR, Wang YT, Cashman NR. Sterol regulatory element binding protein-1 (SREBP1) activation in motor neurons in excitotoxicity and amyotrophic lateral sclerosis (ALS): Indip, a potential therapeutic peptide. Biochemical and Biophysical Research Communications. 413: 159-63. PMID 21871872 DOI: 10.1016/j.bbrc.2011.08.011  0.68
2009 Taghibiglou C, Martin HG, Lai TW, Cho T, Prasad S, Kojic L, Lu J, Liu Y, Lo E, Zhang S, Wu JZ, Li YP, Wen YH, Imm JH, Cynader MS, et al. Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries. Nature Medicine. 15: 1399-406. PMID 19966780 DOI: 10.1038/nm.2064  0.68
2009 Taghibiglou C, Bradley CA, Gaertner T, Li Y, Wang Y, Wang YT. Mechanisms involved in cholesterol-induced neuronal insulin resistance. Neuropharmacology. 57: 268-76. PMID 19523477 DOI: 10.1016/j.neuropharm.2009.05.013  0.68
2009 Taghibiglou C, Martin HG, Rose JK, Ivanova N, Lin CH, Lau HL, Rai S, Wang YT, Rankin CH. Essential role of SBP-1 activation in oxygen deprivation induced lipid accumulation and increase in body width/length ratio in Caenorhabditis elegans. Febs Letters. 583: 831-4. PMID 19187779 DOI: 10.1016/j.febslet.2009.01.045  0.68
2008 Bradley CA, Taghibiglou C, Collingridge GL, Wang YT. Mechanisms involved in the reduction of GABAA receptor alpha1-subunit expression caused by the epilepsy mutation A322D in the trafficking-competent receptor. The Journal of Biological Chemistry. 283: 22043-50. PMID 18534981 DOI: 10.1074/jbc.M801708200  0.68
2008 Peineau S, Bradley C, Taghibiglou C, Doherty A, Bortolotto ZA, Wang YT, Collingridge GL. The role of GSK-3 in synaptic plasticity. British Journal of Pharmacology. 153: S428-37. PMID 18311157 DOI: 10.1038/bjp.2008.2  0.68
2007 Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, Lo E, Wu D, Saule E, Bouschet T, Matthews P, Isaac JT, Bortolotto ZA, Wang YT, Collingridge GL. LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron. 53: 703-17. PMID 17329210 DOI: 10.1016/j.neuron.2007.01.029  0.68
2006 Mielke JG, Taghibiglou C, Wang YT. Endogenous insulin signaling protects cultured neurons from oxygen-glucose deprivation-induced cell death. Neuroscience. 143: 165-73. PMID 16978790 DOI: 10.1016/j.neuroscience.2006.07.055  0.68
2005 Mielke JG, Taghibiglou C, Liu L, Zhang Y, Jia Z, Adeli K, Wang YT. A biochemical and functional characterization of diet-induced brain insulin resistance. Journal of Neurochemistry. 93: 1568-78. PMID 15935073 DOI: 10.1111/j.1471-4159.2005.03155.x  0.68
2005 Qiu W, Taghibiglou C, Avramoglu RK, Van Iderstine SC, Naples M, Ashrafpour H, Mhapsekar S, Sato R, Adeli K. Oleate-mediated stimulation of microsomal triglyceride transfer protein (MTP) gene promoter: implications for hepatic MTP overexpression in insulin resistance. Biochemistry. 44: 3041-9. PMID 15723548 DOI: 10.1021/bi047803+  0.68
2004 Wang Y, Ju W, Liu L, Fam S, D'Souza S, Taghibiglou C, Salter M, Wang YT. alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype glutamate receptor (AMPAR) endocytosis is essential for N-methyl-D-aspartate-induced neuronal apoptosis. The Journal of Biological Chemistry. 279: 41267-70. PMID 15319422 DOI: 10.1074/jbc.C400199200  0.68
2004 Ahmadian G, Ju W, Liu L, Wyszynski M, Lee SH, Dunah AW, Taghibiglou C, Wang Y, Lu J, Wong TP, Sheng M, Wang YT. Tyrosine phosphorylation of GluR2 is required for insulin-stimulated AMPA receptor endocytosis and LTD. The Embo Journal. 23: 1040-50. PMID 14976558 DOI: 10.1038/sj.emboj.7600126  0.68
2003 Man HY, Wang Q, Lu WY, Ju W, Ahmadian G, Liu L, D'Souza S, Wong TP, Taghibiglou C, Lu J, Becker LE, Pei L, Liu F, Wymann MP, MacDonald JF, et al. Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons. Neuron. 38: 611-24. PMID 12765612 DOI: 10.1016/S0896-6273(03)00228-9  0.68
2002 Carpentier A, Taghibiglou C, Leung N, Szeto L, Van Iderstine SC, Uffelman KD, Buckingham R, Adeli K, Lewis GF. Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. The Journal of Biological Chemistry. 277: 28795-802. PMID 12048212 DOI: 10.1074/jbc.M204568200  0.68
2002 Bonn V, Cheung RC, Chen B, Taghibiglou C, Van Iderstine SC, Adeli K. Simvastatin, an HMG-CoA reductase inhibitor, induces the synthesis and secretion of apolipoprotein AI in HepG2 cells and primary hamster hepatocytes. Atherosclerosis. 163: 59-68. PMID 12048122 DOI: 10.1016/S0021-9150(01)00754-7  0.68
2002 Mangaloglu L, Cheung RC, Van Iderstine SC, Taghibiglou C, Pontrelli L, Adeli K. Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity. Metabolism: Clinical and Experimental. 51: 409-18. PMID 11912545 DOI: 10.1053/meta.2002.30954  0.68
2002 Taghibiglou C, Van Iderstine SC, Kulinski A, Rudy D, Adeli K. Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor. Biochemical Pharmacology. 63: 349-60. PMID 11853686 DOI: 10.1016/S0006-2952(01)00918-2  0.68
2002 Taghibiglou C, Rashid-Kolvear F, Van Iderstine SC, Le-Tien H, Fantus IG, Lewis GF, Adeli K. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. The Journal of Biological Chemistry. 277: 793-803. PMID 11598116 DOI: 10.1074/jbc.M106737200  0.68
2001 Adeli K, Taghibiglou C, Van Iderstine SC, Lewis GF. Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends in Cardiovascular Medicine. 11: 170-6. PMID 11597827 DOI: 10.1016/S1050-1738(01)00084-6  0.68
2000 Taghibiglou C, Rudy D, Van Iderstine SC, Aiton A, Cavallo D, Cheung R, Adeli K. Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes. Journal of Lipid Research. 41: 499-513. PMID 10744770  0.68
2000 Taghibiglou C, Carpentier A, Van Iderstine SC, Chen B, Rudy D, Aiton A, Lewis GF, Adeli K. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. The Journal of Biological Chemistry. 275: 8416-25. PMID 10722675 DOI: 10.1074/jbc.275.12.8416  0.68
Show low-probability matches.